Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Clorox Co    CLX

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

The Clorox Company : Refutes Silent Spring Institute's Study on Our Consumer Products

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2012 | 03:26pm CET

We have reviewed the findings of Silent Spring's study claiming some U.S. consumer products contain endocrine-disrupting and asthma-related ingredients.

Product safety is a top priority at The Clorox Company and our company guidelines prohibit using endocrine-disrupting ingredients in our products. For those household products containing fragrance ingredients some consider to be asthma related, these ingredients are present at such low concentrations they do not cause irritation or trigger asthma when used as directed.

Our highly skilled scientists evaluate each product's safety, efficacy and regulatory compliance before it makes it to store shelves. Our safety assessments begin with analysis of each of the materials that go into making the product. This includes consideration of short-term and long-term impact from all types of exposures, including incidental or accidental, and routes of exposure such as skin, eye, ingestion and inhalation. Our safety evaluation also includes the assessment of fragrances, dyes, and preservatives, and other proprietary ingredients, in our formulations.

Clorox voluntarily discloses all ingredients for our U.S. and Canadian household cleaning and disinfecting products through our industry-leading initiative, Ingredients Inside (www.IngredientsInside.com), which is available on our corporate web site and mobile platforms.

For more information on our product stewardship guidelines, visit http://www.thecloroxcompany..


share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CLOROX CO
02/17 CLOROX CO : Post Earnings Coverage as Clorox's Q2 Top-line Registered a 4.5 Perc..
02/16 CLOROX : E2open Congratulates Four Customers for Winning SCM World's Power of th..
02/10 CLOROX CO /DE/ : Entry into a Material Definitive Agreement, Termination of a Ma..
02/09 CLOROX : Innovation Leader Russell Weiner Appointed to Clorox Board
02/08 CLOROX : Announces Feb. 22 Webcast of Company Presentation at 2017 CAGNY Confere..
02/08 CLOROX : Declares Regular Quarterly Dividend of 80 Cents Per Share
02/07 CLOROX PROFESSIONAL PRODUCTS COMPANY : Introduces New Portfolio of Odor Control ..
02/07 CLOROX : NAD Recommends Reynolds Discontinue Certain Claims for Hefty Bags Follo..
02/03 CLOROX : DE/ Management's Discussion and Analysis of Financial Condition and Res..
02/03 CLOROX : CLX) Gains with Earnings in Wings
More news
Sector news : Household Products - NEC
02/22 Opioid-maker Indivior's shares slump on worries of lawsuit costs
02/11DJReckitt Agrees to Mead Deal -- WSJ
02/11DJWHAT'S NEWS : Business & Finance -- WSJ
02/10 FTSE gets mining boost, hits three-week high
02/10DJRECKITT BENCKISER : to Buy Mead Johnson for $16.6 Billion -- 4th Update
More sector news : Household Products - NEC
News from SeekingAlpha
02/23 Can 20 Financial Ratios Measure A Company's Moat Just Like Morningstar? Updat..
02/23 S&P Aristocrat Dog 'Safe' Yields For February Piloted By AbbVie, Chevron, And..
02/22 Free Market Capitalist January Dividend Income
02/20 RETIREMENT : Transitioning To The Distribution Phase - First Year In The Books
02/17 3 Top Defensive Stocks For 2017
Advertisement
Financials ($)
Sales 2017 5 982 M
EBIT 2017 1 130 M
Net income 2017 697 M
Debt 2017 1 937 M
Yield 2017 2,37%
P/E ratio 2017 25,69
P/E ratio 2018 23,83
EV / Sales 2017 3,25x
EV / Sales 2018 3,13x
Capitalization 17 492 M
More Financials
Chart CLOROX CO
Duration : Period :
Clorox Co Technical Analysis Chart | CLX | US1890541097 | 4-Traders
Full-screen chart
Technical analysis trends CLOROX CO
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 128 $
Spread / Average Target -6,3%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Benno O. Dorer Chairman & Chief Executive Officer
Dawn C. Willoughby COO-Cleaning, International & Corporate Strategy
Stephen M. Robb Chief Financial Officer & Executive Vice President
Manjit Singh Chief Information Officer & Senior Vice President
Robert W. Matschullat Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CLOROX CO13.17%17 492
RECKITT BENCKISER GROU..2.74%63 781
UNILEVER INDONESIA TBK..--.--%24 178
CHURCH & DWIGHT CO., I..12.29%12 809
LION CORP0.57%5 138
KOBAYASHI PHARMACEUTIC..4.39%3 825
More Results